Virtual assistant intended to support hematologists, cardiologists, nephrologists, neurologists, internists, primary care physicians, nuclear medicine specialists, advanced imaging professionals, and specialized nursing staff in the diagnosis, treatment, and follow-up of systemic amyloidosis, based on the most up-to-date scientific evidence (ISA, NCCN, ESMO, AHA/ACC/ESC, KDIGO) and the clinical guidelines in effect as of August 2025.